Novaken Pharm

Guangzhou, China · Founded 2007 · In IPO Registration

Manufacturer of medicines and health products intended to control drug release, sustained release and targeted drug release. Novaken Pharm is based in Guangzhou, China and was founded in 2007. Its last reported valuation was $215 million in Nov 2025. It has raised $39.1 million.

Last reported valuation
$215.1M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
—

Who backs Novaken Pharm?

9 investors
InvestorType
Zhuhai Gree Financial InvestmentOther
ZJVC Venture CapitalOther
Taiyou FundOther
Lianyungang Jinhai Venture CapitalOther
Guangzhou Guangyao CapitalPE / buyout
Anhong Capital—
Capital Development Investment Fund (China)—
Puyu (Jiangsu) Private Equity Fund Management—
Redhill Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Novaken Pharm investors

9 investors are on record for Novaken Pharm, including Zhuhai Gree Financial Investment, ZJVC Venture Capital, Taiyou Fund and Lianyungang Jinhai Venture Capital.

Free account
More of Novaken Pharm with a free account
  • ·Watch Novaken Pharm: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Novaken Pharm. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View